servickuz / shutterstock.com
16 January 2020EuropeRory O'Neill
Breaking: EPO revokes Broad’s CRISPR patent
In a dramatic reversal, a European Patent Office’s (EPO) board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.
In a dramatic reversal, a European Patent Office’s (EPO) board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.
